164 related articles for article (PubMed ID: 36065540)
1. Dual role of basophils in the pathogenesis of bullous pemphigoid elucidated by pathological and ultrastructural studies.
Kimura R; Sugita K; Horie T; Yamamoto O
Eur J Dermatol; 2022 May; 32(3):322-333. PubMed ID: 36065540
[TBL] [Abstract][Full Text] [Related]
2. Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid.
Limberg MM; Weihrauch T; Gray N; Ernst N; Hartmann K; Raap U
Biomolecules; 2023 Jun; 13(7):. PubMed ID: 37509055
[TBL] [Abstract][Full Text] [Related]
3. Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.
Borrego L; Maynard B; Peterson EA; George T; Iglesias L; Peters MS; Newman W; Gleich GJ; Leiferman KM
Am J Pathol; 1996 Mar; 148(3):897-909. PubMed ID: 8774144
[TBL] [Abstract][Full Text] [Related]
4. Bullous Pemphigoid Masquerading as Erythema Annulare Centrifugum.
Yu-Yang S; Chu-Sung Hu S; Yiao-Lin S
Acta Dermatovenerol Croat; 2017 Oct; 25(3):255-256. PubMed ID: 29252183
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a role of eosinophils in blister formation in bullous pemphigoid.
de Graauw E; Sitaru C; Horn M; Borradori L; Yousefi S; Simon HU; Simon D
Allergy; 2017 Jul; 72(7):1105-1113. PubMed ID: 28135772
[TBL] [Abstract][Full Text] [Related]
6. Role of cell-mediated immune reaction in blister formation of bullous pemphigoid.
Kaneko F; Minagawa T; Takiguchi Y; Suzuki M; Itoh N
Dermatology; 1992; 184(1):34-9. PubMed ID: 1558993
[TBL] [Abstract][Full Text] [Related]
7. Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient.
Dvorak AM; Mihm MC; Osage JE; Kwan TH; Austen KF; Wintroub BU
J Invest Dermatol; 1982 Feb; 78(2):91-101. PubMed ID: 7035575
[TBL] [Abstract][Full Text] [Related]
8. Tissue eosinophil levels as a marker of disease severity in bullous pemphigoid.
Gore Karaali M; Koku Aksu AE; Cin M; Leblebici C; Kara Polat A; Gurel MS
Australas J Dermatol; 2021 May; 62(2):e236-e241. PubMed ID: 33748980
[TBL] [Abstract][Full Text] [Related]
9. High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid.
Kakinuma T; Wakugawa M; Nakamura K; Hino H; Matsushima K; Tamaki K
Br J Dermatol; 2003 Feb; 148(2):203-10. PubMed ID: 12588369
[TBL] [Abstract][Full Text] [Related]
10. Childhood bullous pemphigoid: a clinicopathologic study and review of the literature.
Fisler RE; Saeb M; Liang MG; Howard RM; McKee PH
Am J Dermatopathol; 2003 Jun; 25(3):183-9. PubMed ID: 12775979
[TBL] [Abstract][Full Text] [Related]
11. Decrease in eosinophils infiltrating into the skin of patients with dipeptidyl peptidase-4 inhibitor-related bullous pemphigoid.
Chijiwa C; Takeoka S; Kamata M; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Watanabe S; Tada Y
J Dermatol; 2018 May; 45(5):596-599. PubMed ID: 29411416
[TBL] [Abstract][Full Text] [Related]
12. Eosinophil-derived galectin-10 upregulates matrix metalloproteinase expression in bullous pemphigoid blisters.
Sato T; Chiba T; Nakahara T; Watanabe K; Sakai S; Noguchi N; Noto M; Ueki S; Kono M
J Dermatol Sci; 2023 Oct; 112(1):6-14. PubMed ID: 37640566
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of patients with bullous pemphigoid: comparison of classic bullous pemphigoid to non-bullous pemphigoid.
Ben Mordehai Y; Faibish H; Astman N; Greenberger S; Barzilai A; Baum S
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):161-165. PubMed ID: 31423677
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils in bullous pemphigoid.
Jones VA; Patel PM; Amber KT
Panminerva Med; 2021 Sep; 63(3):368-378. PubMed ID: 32536149
[TBL] [Abstract][Full Text] [Related]
15. Distinct compartmentalization of immune cells and mediators characterizes bullous pemphigoid disease.
Margaroli C; Bradley B; Thompson C; Brown MR; Giacalone VD; Bhatt L; Stoff B; Ahuja S; Springman E; Tirouvanziam R; Feldman RJ
Exp Dermatol; 2020 Dec; 29(12):1191-1198. PubMed ID: 33047366
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of interleukin-9 in the serum of bullous pemphigoid: possible association with the pathogenicity of bullous pemphigoid.
Koga H; Teye K; Sugawara A; Tsutsumi M; Ishii N; Nakama T
Front Immunol; 2023; 14():1135002. PubMed ID: 37398641
[TBL] [Abstract][Full Text] [Related]
17. Blister Fluid Induces MMP-9-Associated M2-Type Macrophages in Bullous Pemphigoid.
Riani M; Muller C; Bour C; Bernard P; Antonicelli F; Le Jan S
Front Immunol; 2019; 10():1858. PubMed ID: 31440247
[TBL] [Abstract][Full Text] [Related]
18. A case of bullous pemphigoid developing under treatment with benralizumab for bronchial asthma.
Tanaka A; Fujimura Y; Fuke S; Izumi K; Ujiie H
J Dermatol; 2023 Sep; 50(9):1199-1202. PubMed ID: 37122191
[TBL] [Abstract][Full Text] [Related]
19. IgE autoantibodies in serum and skin of non-bullous and bullous pemphigoid patients.
Lamberts A; Kotnik N; Diercks GFH; Meijer JM; Di Zenzo G; Pas HH; Jonkman MF; Gibbs BF; Raap U; Horváth B
J Eur Acad Dermatol Venereol; 2021 Apr; 35(4):973-980. PubMed ID: 33058320
[TBL] [Abstract][Full Text] [Related]
20. Cellular events leading to blister formation in bullous pemphigoid.
Dubertret L; Bertaux B; Fosse M; Touraine R
Br J Dermatol; 1980 Dec; 103(6):615-24. PubMed ID: 7006666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
